ADO

0.00%

2.1¢ anteotech ltd

Let's wait of the results from the Troponin-Test trials from...

First 2 Last

Share
Profile

Follow
secondsight

612 Posts.

305

29/12/17

06:25

Post #: 29921663
Share

Originally posted by StretchR ↑

If I might interrupt some of the posting that seems to largely reflect personal views to ask a couple of questions which have arisen from personal experience!

On visiting the big city a little over a week before Christmas I found myself taking a close relative who had experience unusual heart activity to the emergency dept of an inner city hospital. At just after 5 am on Sunday morning it was uncharacteristically quiet, at least initially. A ECG was taken (all clear) and a blood sample taken (presumably looking at troponin levels). The relative was taken into the ED area around 6am. An Xray was ordered and carried out. At least an hour and a half later the bloods came back negative. On the results available then a further blood check of thyroid activity was ordered. These took over two hours. It too came back negative but a member of the nursing staff indicated that if my relative has shown symptoms more characteristic of a heart attack the patient is held for another 2 to 3 hours and a second troponin blood test is done!

In the next bed a guy had experienced black outs at a function the night before and was convinced by family to go to the ED in the morning. He was subject to a barrage of scans of various types and blood testing carried out. His results were going to take some time so he was wheeled to an adjoining area where he was placed in " a holding pattern" until results came back thus freeing his bed in what was then becoming a crowded ED treatment area.

While waiting and watching the activity I started to wonder where we are at with:
(1) has all hand troponin device development ceased? (Philips and others??)
(2) have ADO's claims been conclusively disproved or are we just reading that into the failure to secure commercial alliances??

My relative was released about 11am with a recommendation to see a cardiologist (which on the evidence was appropriate response)

I can't help but feel that there is a huge need for quicker and perhaps more accurate testing in EDs. I would think that given the political hoo-ha that goes on about waiting and discharge times at EDs that health departments and their ministers should be screaming for it.

So I ask again. Is it:
(1) ADO's product (2) ADO's administration (3) Big Pharma playing their "games of renown"
that has caused this halt in development? I realise that these questions are behind most of the postings made here but I have expressed them in this way in the hope that obviously well meaning and concerned people will refocus on the evidence and not give way to " tribal football club" like allegiances!

Expand

Let's wait of the results from the Troponin-Test trials from Atome / Anteo.
You're right, we need better and faster results from these tests, without labs.

ADO Price at posting: 1.6¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Bitcoin investors need to know the risks

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

There are more pages in this discussion • 10 more messages in this thread...

First 2 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.1¢		Change 0.000(0.00%)		Mkt cap ! $51.83M

Open	High	Low	Value	Volume
2.1¢	2.2¢	2.1¢	$3.414K	161.6K

Buyers (Bids)

No.	Vol.	Price($)
4	384663	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.2¢	616353	6

View Market Depth

No.	Vol.	Price($)
4	384663	0.021
12	2157550	0.020
10	3040767	0.019
10	1652665	0.018
3	94160	0.017

Price($)	Vol.	No.
0.022	616353	6
0.023	857853	5
0.024	1306228	3
0.025	214144	4
0.027	680612	2

Last trade - 16.10pm 12/07/2024 (20 minute delay)

ADO (ASX) Chart

Let's wait of the results from the Troponin-Test trials from...

Bitcoin investors need to know the risks

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Immutep reports strong response rate from immunotherapies treating carcinomas

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nimy to raise $1.21M to explore 'newsy' WA targets

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Let's wait of the results from the Troponin-Test trials from...

Top Stories

Bitcoin investors need to know the risks

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Immutep reports strong response rate from immunotherapies treating carcinomas

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nimy to raise $1.21M to explore 'newsy' WA targets

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News